SCHEMBL8407301

SCHEMBL8407301

NC(=O)C[C@H](N)c1ccc(O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.47
ESR1 P03372 3/20 0.43
ALOX15 P16050 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
CYP3A4 P08684 2/20 0.43
LMNA P02545 2/20 0.43
CYP1A2 P05177 1/20 0.43
PGR P06401 1/20 0.43
CHRM2 P08172 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
AR P10275 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
CHRM1 P11229 1/20 0.43
CYP2C9 P11712 1/20 0.43
DRD1 P21728 1/20 0.43
TBXA2R P21731 1/20 0.43
PTGS1 P23219 1/20 0.43
SLC6A2 P23975 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27735171 1.00 CA2 (0.47) CA2ESR1ALOX15TDP1CYP3A4
SCHEMBL284828 0.83 KMT2A (0.46) CA2ALOX15TDP1CYP3A4LMNA
SCHEMBL3554163 0.83 KMT2A (0.46) CA2ALOX15TDP1CYP3A4LMNA
SCHEMBL2765505 0.83 KMT2A (0.46) CA2ALOX15TDP1CYP3A4LMNA
SCHEMBL14785618 0.82 CYP2C9 (0.50) CYP3A4LMNACYP1A2ADORA3CYP2D6
Bicarbonate SCHEMBL15743197 0.82 KMT2A (0.45) CA2ALOX15TDP1CYP3A4LMNA
SCHEMBL5360485 0.82 DPP9 (0.43) ANPEP
SCHEMBL19810879 0.82 CYP2C9 (0.50) CYP3A4LMNACYP1A2ADORA3CYP2D6
SCHEMBL390453 0.82 CYP2C9 (0.50) CYP3A4LMNACYP1A2ADORA3CYP2D6
SCHEMBL1231305 0.81 CYP2C19 (0.53) LMNACYP1A2ADORA3CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5939279-A BLOCKING ATTACHMENT OF BACTERIA TO INTESTINAL EPITHELIAL BRUSH BORDER CELLS BY CONTACTING CELLS WITH OLIGOSACCHARIDE WITH MORE THAN 6 MANNOSE RESIDUES; PROPHYLAXIS AGAINST ENTEROBACTER CLOACAE THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) 1999-08-17 US disclosed